# Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women

> **NCT00704912** · PHASE2 · COMPLETED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 217 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Orlistat/Meal Replacement/Lifestyle Modification
- **DRUG:** Loestrin 1/20
- **DRUG:** Combination of treatments

## Key facts

- **NCT ID:** NCT00704912
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2016-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00704912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00704912, "Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00704912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*